Reaction Details |
| Report a problem with these data |
Target | Sodium-dependent noradrenaline transporter |
---|
Ligand | BDBM218671 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Uptake Assay |
---|
IC50 | 293.3±n/a nM |
---|
Citation | Kortagere, S; Kuzhikandahil, EV D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease US Patent US9289400 Publication Date 3/22/2016 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Sodium-dependent noradrenaline transporter |
---|
Name: | Sodium-dependent noradrenaline transporter |
Synonyms: | Monoamine transporter | NAT1 | NET | NET1 | Noradrenaline Transporter (NET) | Norepinephrine Transporter (NET) | Norepinephrine transporter protein (NET) | SC6A2_HUMAN | SLC6A2 | SLC6A5 | Sodium-dependent noradrenaline transporter (NET) | Solute carrier family 6 member 2 |
Type: | Multi-pass membrane protein |
Mol. Mass.: | 69337.72 |
Organism: | Homo sapiens (Human) |
Description: | P23975 |
Residue: | 617 |
Sequence: | MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWG
KKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYN
REGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTW
NSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLC
LMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFY
RLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFA
IFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSS
MGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTS
ILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINF
KPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHL
VAQRDIRQFQLQHWLAI
|
|
|
BDBM218671 |
---|
n/a |
---|
Name | BDBM218671 |
Synonyms: | US9289400, ES609 |
Type | Small organic molecule |
Emp. Form. | C10H14ClN |
Mol. Mass. | 183.678 |
SMILES | CC(N)CCc1ccccc1Cl |
Structure |
|